Latest Regulatory Approvals News

EMVision Medical Devices has received a $4.3 million R&D tax refund, adding non-dilutive funding as it progresses clinical work on its emu™ and First Responder devices. The cash arrives against a last reported cash balance of $17.1 million and $4.6 million in remaining grant funding at 30 June 2026.

Tyranna Resources has signed a binding earn-in agreement covering the 830 km² Coola Rare Earths and Niobium Project in Angola, with two carbonatite-bearing intrusions already mapped. The deal remains conditional on renewal of the project tenement, while a proposed 500 million-option grant adds a significant shareholder-approval question.

Nufarm is pairing a narrower crop-protection portfolio with heavier investment in seeds and tighter capital controls as it targets A$370 million to A$380 million in FY26 underlying EBITDA. The company has reaffirmed positive free cash flow, leverage of about 2.0 times and a A$50 million cost-saving program due to reach run-rate by the end of FY27.

Northern Star has unanimously rejected Gold Fields' unsolicited takeover proposal, saying its mixed cash-and-scrip offer undervalued the company and arrived ahead of important operational milestones. The implied value of the proposal has since fallen from A$27.00 to A$25.19 per Northern Star share.

St Barbara is positioning itself as a debt-free Nova Scotia gold developer after a proposed A$453 million Simberi exit, with a potential special dividend and share buy-back still on the table. Its updated 15-Mile study points to a larger reserve, longer mine life and stronger project economics, but those figures remain study-based and conditional on execution.

Synlait’s operational recovery gathered pace in the second half, but the NZX-listed dairy processor still reported a NZ$75.4 million FY26 loss and negative operating cash flow. KPMG flagged a material uncertainty over going concern as the company prepares to refinance facilities due in 2027.

US1 Critical Minerals has warned of a material uncertainty over its ability to continue as a going concern, with only $302,641 in cash at year-end. Its forecast depends heavily on completing a conditional sale of Tanzanian uranium licences for an initial US$1 million.

Strata Minerals has shifted from broad exploration to a Zelica-centred Western Australian gold strategy, pairing strong drilling results with a proposed capital-light mining pathway funded by BML Ventures. The opportunity is growing, but the company remains loss-making and warns that further funding may be required to continue as a going concern.

Raiden Resources posted a wider FY2026 loss after impairing A$8.86 million of exploration assets, while its cash and term deposits fell to A$11.98 million. The company is now concentrating on Brazil’s Crixás gold tailings project, Bulgarian exploration and a proposed divestment of most of Mt Sholl.

Nexsen has proposed a 50:50 joint venture with FlashDx Shenzhen to develop and commercialise an enhanced molecular Group B Streptococcus test, using an existing CE-marked platform as its starting point. The proposed venture could shorten Nexsen’s path into hospital and intrapartum testing across Asia-Pacific, but the term sheet remains non-binding and regulatory work is still ahead.

Image Resources has confirmed LB Group has paid a A$5 million advance while negotiations continue over a potential transaction involving significant interests in its Durack and Yandanooka projects. The payment is repayable if binding documents are not signed by 31 October 2026, unless the parties agree to extend that date.

Kelsian Group delivered record FY26 earnings and lifted its fully franked dividend, while preparing to become a more focused bus, coach and ferry operator. The next test is execution: completing the conditional tourism sale, mobilising new contracts and delivering against FY27 EBITDA guidance.